Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Dividend Stocks Billionaire Steve Cohen Really Likes

Page 1 of 2

Although his family office isn’t technically a hedge fund anymore (a settlement with the SEC saw to that), many on Wall Street still regard billionaire Steve Cohen‘s Point72 Asset Management as one of the savviest institutions in the marketplace. Not only does the firm have one of the better risk-adjusted performance metrics in the industry (Cohen became a billionaire 13 times over from managing money, albeit mostly while running SAC, his fund’s former moniker), but the best and brightest still work for Point72.

Given those facts, Insider Monkey has put together a list of some of Steven Cohen’s favorite dividend stocks, which are ConocoPhillips (NYSE:COP), KAR Auction Services Inc (NYSE:KAR), Tesoro Corporation (NYSE:TSO), Eli Lilly and Co (NYSE:LLY), and Schlumberger Limited. (NYSE:SLB). Let’s take a closer look at these stocks and see how they were being traded in the second quarter.

At Insider Monkey, we track around 750 hedge funds and institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on, can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see the details here).

Steven Cohen

#5 Schlumberger Limited. (NYSE:SLB)

– Shares Held (as of June 30): 1.11 million
– Total Value (as of June 30): $87.46 million

Although crude oil is still more than 50% below its 2014 highs, Schlumberger Limited. (NYSE:SLB) has done well in 2016, with its stock rising by more than 11% year-to-date. One reason for the solid performance is that the oil service company’s management has successfully managed costs in the face of revenue declines. Another reason is that given its pricing power, investors expect Schlumberger to raise its prices when oil goes higher, which could be sooner rather than later, as many investors think that OPEC will eventually relent. That means the company’s current quarterly dividend of $0.50 per share, good for a 2.62% annual yield, looks safe. Point72 almost tripled its position in the company from March 31 to June 30, adding 722,950 shares in the second quarter.

Follow Schlumberger Limited (NYSE:SLB)
Trade (NYSE:SLB) Now!

#4 Eli Lilly and Co (NYSE:LLY)

– Shares Held (as of June 30): 1.35 million
– Total Value (as of June 30): $106.34 million

Cohen’s fund inched up its stake in Eli Lilly and Co (NYSE:LLY) by 9% in the second quarter, to 1.35 million shares worth over $106 million at the end of June. Although there are higher yields in biotech/healthcare (Eli Lilly pays a dividend of $2.04 per share a year, for a 2.59% yield), there are few drug companies that have as promising of a pipeline as Eli Lilly. According to recent commentary from its management team, Eli Lilly is still on track to launch drugs or molecules for at least two new indications/line extensions per year for the next seven years and management fully expects to announce annual dividend raises each year until 2020.

Follow Lilly Eli & Co (NYSE:LLY)
Trade (NYSE:LLY) Now!

We’ll check out three more dividend stocks favored by Steve Cohen and his team on the next page.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!